We first demonstrated enhanced expression of SET domain-containing histone methyltransferases in whole lysates of all classes of renal carcinoma, namely clear cell carcinoma, chromophobe carcinoma and papillary carcinoma. Here, PRDM9 is linked to thyroid gland papillary carcinoma.